Skip to main content
. 2017 May 24;2017:9456785. doi: 10.1155/2017/9456785

Figure 4.

Figure 4

The measurements of transaminases levels at 1 d, 3 d, 5 d, 7 d, 22 d, 44 d, and 46 d after prolonged and repeated oral administration of PMR: oral administration of PMR to rats for 1–7 d, 1 d after 2 w stop (interval), 1–3 d for 3 w stop, and 37 d for transaminases level during oral administration interval (x-±s,n=5). (a) and (b) for ALT level. (c) and (d) for AST level. Significant difference compared with other groups, P < 0.05. ∗∗Extremely significant difference compared with other groups, P < 0.01.